April 26, 2021
A population-based screening program for atrial fibrillation (AF) improved clinical outcomes in 75- and 76-year-olds living in two regions of Sweden, the randomized STROKESTOP shows.
Over more than 5 years of follow-up, risk of the combined primary endpoint of ischemic stroke, systemic thromboembolism, all-cause mortality, hemorrhagic stroke, or hospitalization for bleeding was significantly lower in the group invited for screening (HR 0.96;
P = 0.045), according to Emma Svennberg, MD, PhD (Karolinska Institutet, Stockholm, Sweden).
The number of people who would have to be invited for screening in order to prevent one event is 91, she reported last week during the virtual European Heart Rhythm Association Congress 2021.
RACE 3: Effects Wane for Targeted Therapy in Early AF, HF tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.